Blog

Windlas Trackrecord

[Stock idea]: Windlas Biotech — 13 quarters in a row of record growth

While most of the market was distracted by largecap pharma names, a smaller CDMO player quietly delivered its 13th consecutive quarter of record revenue. No new drug launch. No big acquisition. Just consistent execution, disciplined capital allocation, and margins that keep inching up. Here’s what caught our eye, but before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst Wealth.   Latest Stock recommendations…

Read More
GPT Healthcare hospital performance

[Stock idea]: GPT Healthcare – This 719-bed hospital chain is scaling to 1,000 beds — here’s the plan

GPT Healthcare (ILS Hospitals) just posted its Q4 & FY26 numbers — and on the surface, it looks like a mixed bag. Revenue grew a healthy 24% YoY in Q4, but full-year PAT actually fell 15%. The reason isn’t operational weakness — it’s a single new hospital in Raipur that’s still ramping up. Strip that out, and the mature network is running at a 23%+ EBITDA margin. Here are my notes from the results, but before that: Help us grow: If…

Read More
Control print long term value driver

[Stock idea]: Control Print – 23,000 printers, ~20% market share, and a 35-year profit machine

Control Print just posted its highest-ever Q4 revenue — ₹134.2 crore, up 21.9% YoY, with EBITDA growing even faster at 24.9%. But the more interesting story is what’s underneath the number: a business quietly compounding an installed base of 23,000+ printers into a high-margin, recurring consumables engine, while placing patient, long-horizon bets on what comes next. In May 2014, we also created a detailed report on the company when it was around 54 odd levels. You can read the report (opens…

Read More
MMP segment wise performance

[Stock idea]: MMP Industries – A fire burned ₹45-50 Cr of revenue. They still posted their best year eve

Most investors look at a PAT number and move on. The investors who find compounders early read the footnotes. MMP Industries just reported its highest-ever quarterly and full-year revenue — and buried inside the numbers are three businesses nobody is talking about yet. Here are my notes, but before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst Wealth.   Latest Stock recommendations for…

Read More